BPG is committed to discovery and dissemination of knowledge
JOURNAL HOME
Number of total visits
33046048
Number of visits today
4889
Number of downloads
16241658
MEMBERSHIP
BPG JOURNALS
Cited by in F6Publishing
For: Schneider G, Wirth M, Keller U, Saur D. Rationale for MYC imaging and targeting in pancreatic cancer. EJNMMI Res 2021;11:104. [PMID: 34637026 DOI: 10.1186/s13550-021-00843-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Demel UM, Wirth M, Yousefian S, Zhang L, Isaakidis K, Dönig J, Böger M, Singh N, Köse H, Haas S, Müller S, Schick M, Keller U. Small-molecule SUMO inhibition for biomarker-informed B-cell lymphoma therapy. Haematologica 2023;108:555-67. [PMID: 36134453 DOI: 10.3324/haematol.2022.280995] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
2 Pershina AG, Nevskaya KV, Morozov KR, Litviakov NV. Methods for assessing the effect of microRNA on stemness genes. Bûll sib med 2023;21:170-182. [DOI: 10.20538/1682-0363-2022-4-170-182] [Reference Citation Analysis]
3 Li Y, Elakad O, Yao S, von Hammerstein-Equord A, Hinterthaner M, Danner BC, Ferrai C, Ströbel P, Küffer S, Bohnenberger H. Regulation and Therapeutic Targeting of MTHFD2 and EZH2 in KRAS-Mutated Human Pulmonary Adenocarcinoma. Metabolites 2022;12:652. [PMID: 35888776 DOI: 10.3390/metabo12070652] [Reference Citation Analysis]
4 Wirth M. Targeting the translational machinery to overcome apoptosis resistance in pancreatic cancer. Transl Oncol 2022;17:101343. [PMID: 35078019 DOI: 10.1016/j.tranon.2022.101343] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
Write to the Help Desk
© 2004-2023 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345